Hikmet Gülben Güç

Hikmet Gülben Güç

Auto-generated profile, based on publicly available information

Hikmet Gülben Güç

Istanbul University

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2026 in Biomedical Chromatography
Verified
Journal Article
Closed access
TITuğba Iduğ
Tuğba Iduğ
HGHikmet Gülben Güç
Hikmet Gülben Güç
IÇIşık Çelik
Işık Çelik
ÜEÜmit Can ERİM
Ümit Can ERİM
Hüseyin Onur TUNCAYHüseyin Onur TUNCAY
Hüseyin Onur TUNCAY

23 October 2026 in İstanbul Journal of Pharmacy
Verified
Journal Article
Closed access
SBSevde Nur Biltekin
Sevde Nur Biltekin
HGHikmet Gülben Güç
Hikmet Gülben Güç
FTFatma Tosun
Fatma Tosun
Background and Aims: The genus Euphorbia L. is widely recognised for its diverse secondary metabolites with potent biological activities. This study aimed to evaluate the total phenolic content as well as the cytotoxic, pro-apoptotic, and anti-inflammatory potential of the methanolic extract of Euphorbia oblongifolia (K.Koch) K.Koch against various human cancer cell lines and inflammatory models to determine its therapeutic viability.Methods: The total phenolic content was quantified using the Folin-Ciocalteu assay. The cytotoxic effects were assessed using the MTT assay on A549, U87MG, PC3, MCF7 and HEK293 cell lines. Apoptotic induction in PC3 cells was quantified through caspase-3 activity. Anti-inflammatory activity was investigated by measuring protein levels in LPS-stimulated RAW 264.7 macrophages and evaluating the enzymatic inhibition of COX-2 enzyme assays.Results: The E. oblongifolia extract possessed a substantial total phenolic content of 98.95 ± 6.11 mg gallic acid equivalent per gram of dry extract. The extract exhibited selective cytotoxicity against PC3 cells (IC50 = 27.33 ± 1.24 μg/mL) and HEK293 cells (IC50 > 100 μg/mL). Treatment of PC3 cells led to a >2-fold increase in caspase-3 levels, confirming apoptosis. Additionally, the extract suppressed LPS-induced TNF-α production and demonstrated significant COX-2 inhibition, achieving a reduction of over 60% in enzymatic activity.Conclusion: These findings suggest that E. oblongifolia possesses a significant dual-action pharmacological profile underpinned by its rich phenolic yield. By selectively inducing apoptosis in cancer cells and modulating key inflammatory mediators, the extract serves as a promising source for the development of new anticancer and anti-inflammatory agents.

3 August 2026 in Journal of Research in Pharmacy
Verified
Journal Article
Closed access
SBSevde Nur Biltekin
Sevde Nur Biltekin
HGHikmet Gülben Güç
Hikmet Gülben Güç
FTFatma Tosun
Fatma Tosun
This study systematically evaluated the in vitro cytotoxic potential of four plant extracts from the Apiaceae family—Artedia squamata L., Astrantia maxima Pall. subsp. maxima, Heracleum platytaenium Boiss., and Selinum alatum(M.Bieb.) Poir.—against a panel of human carcinoma cell lines (A549, PC3, MCF7, and U87MG), providing novel insights into the dynamics of oncogenic progression through advanced analyses. Notably, this research represents the first comprehensive report on the anti-proliferative activities of these specific extracts against both malignant and non-malignant human cell lines. Our findings, obtained via the MTT assay using colchicine as a positive control, reveal that H. platytaenium and S. alatum are highly potent cytotoxic agents, exhibiting remarkably low IC50 values. Crucially, while the positive control colchicine proved highly toxic to healthy cells (IC50 = 31.27 ± 1.03 µg/mL), all investigated extracts demonstrated an exceptional safety profile, showing no significant cytotoxicity against the non-malignant human embryonic kidney cell line (HEK293, IC50 > 100 µg/mL). The high selectivity index of these extracts, evidenced by their robust inhibition of malignant cells coupled with their biocompatibility with normal tissues, underscores their pharmacological significance. Furthermore, the significant inhibitory effects of these potent extracts on the MAPK pathway—a master regulator of carcinogenesis—alongside their modulation of Caspase-3 activity, constitute substantial data newly contributed to the literature. These results identify the studied taxa, particularly H. platytaenium, as promising and safe natural candidates for the discovery of novel anticancer therapeutics, warranting further investigation.